🔴 Zevra Therapeutics is trading 5% down today as Brent crude tops $100 amid U.S.-Iran escalation

Zevra Therapeutics is trading 5% down at $12.04 as risk-off conditions weigh on equities.

• The S&P 500, Nasdaq Composite, and Dow Jones are all lower.
• Brent crude has surpassed $100 per barrel amid U.S.-Iran military escalation, pressuring sentiment across growth stocks.
• A September 9 Cantor conference highlighted solid MIPLYFFA adoption but continuing European regulatory and development risks.